Passage Bio, Inc.
Key Metrics
Market Snapshot
About
Passage Bio is a clinical-stage genetic medicines company focused on developing AAV-delivered gene therapies for central nervous system disorders. The company leverages its platform to target rare neurological diseases with potentially transformative one-time treatments, aiming to address significant unmet medical needs in CNS conditions.